# Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)

> **NCT01408056** · PHASE2 · WITHDRAWN · sponsor: **Children's Hospital of Philadelphia**

## Conditions studied

- Infantile Hemangiomas

## Interventions

- **DRUG:** Timolol 0.5% Gel Forming Solution (GFS)
- **DRUG:** Mupirocin 2% Ointment

## Key facts

- **NCT ID:** NCT01408056
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-02
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Difficulty with recruitment
- **Last updated:** 2014-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01408056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01408056, "Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01408056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*